Commentary: When to start and what to use in children--recommendations and rationale.
aMaternal and Pediatric Infectious Disease (MPID) Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA bANECCA, Kampala, Uganda.
George
G
Siberry
Denis
D
Tindyebwa
D044966:Anti-Retroviral Agents / Q000008:administration & dosage*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*
D044966:Anti-Retroviral Agents